Connect your AI

Boston Scientific BSX Gross Profit

Gross Profit at other companies

AbbottABT

$6.27B+6.5%

TFX

TeleflexTFX

$307.43M+20.4%

Johnson & JohnsonJNJ

$15.96B+9.8%

StrykerSYK

$3.81B+1.8%

HaemoneticsHAE

$198.21M+2.7%

CONMEDCNMD

$183.45M+3.2%

Other financials

Income statement

Revenue$5.2B+11.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

Market cap$65.7B-56.2%

P/E18.5×-55.6×

P/S3.2×-5.4×

Profitability

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

FCF margin16.9%-0.3pp

Returns & leverage

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Calculated from Boston Scientific’s reported figures.

$5.2Btotal revenue−$1.6Btotal cost of revenue=$3.61B

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Boston Scientific's gross profit?: Boston Scientific (BSX) reported gross profit of $3.61B in Q1 2026.
How has Boston Scientific's gross profit changed year-over-year?: Boston Scientific's gross profit increased by 12.6% year-over-year, from $3.21B to $3.61B.
What is the long-term trend for Boston Scientific's gross profit?: Over 4 years (2021 to 2025), Boston Scientific's gross profit has grown at a 14.1% compound annual growth rate (CAGR), from $8.18B to $13.85B.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.